Fitness
The impact of intimate partner violence on PrEP adherence among U.S. Cisgender women at risk for HIV – BMC Public Health
Centers for Disease Control and Prevention. Estimated HIV incidence and prevalence in the United States, 2010–2016. 2019.
Geter A, Sutton MY, Armon C, Buchacz K. Disparities in viral suppression and medication adherence among women in the USA, 2011–2016. AIDS Behav. 2019;23(11):3015–23.
Flash CA, Dale SK, Krakower DS. Pre-exposure prophylaxis for HIV prevention in women: current perspectives. Int J Womens Health. 2017;9:391–401.
Willie TC, Kershaw TS, Blackstock O, Galvao RW, Safon CB, Tekeste M, et al. Racial and ethnic differences in women’s HIV risk and attitudes towards pre-exposure prophylaxis (PrEP) in the context of the substance use, violence, and depression syndemic. AIDS Care. 2021;33(2):219–28.
Tsuyuki K, Chan E, Lucea MB, Cimino A, Rudolph AE, Tesfai Y, et al. Characterising a syndemic among black women at risk for HIV: the role of sociostructural inequity and adverse childhood experiences. Sex Transm Infect. 2023;99(1):7–13.
Leddy AM, Zakaras JM, Shieh J, Conroy AA, Ofotokun I, Tien PC, Weiser SD. Intersections of food insecurity, violence, poor mental health and substance use among US women living with and at risk for HIV: evidence of a syndemic in need of attention. PLoS ONE. 2021;16(5):e0252338.
Montgomery BEE, Rompalo A, Hughes J, Wang J, Haley D, Soto-Torres L, et al. Violence against women in selected areas of the United States. Am J Public Health. 2015;105(10):2156–66.
Leemis RW, Friar N, Khatiwada S, Chen MS, Kresnow M-j, Smith SG et al. The National Intimate Partner and Sexual Violence Survey: 2016/2017 Report on Intimate Partner Violence. 2022.
Sales JM, Salazar LF, Wingood GM, DiClemente RJ, Rose E, Crosby RA. The mediating role of partner communication skills on HIV/STD–associated risk behaviors in young African American females with a history of sexual violence. Arch Pediatr Adolesc Med. 2008;162(5):432–8.
Kalichman SC, Gore-Felton C, Benotsch E, Cage M, Rompa D. Trauma symptoms, sexual behaviors, and substance abuse: correlates of childhood sexual abuse and HIV risks among men who have sex with men. J Child Sex Abuse. 2004;13(1):1–15.
Braksmajer A, Senn TE, McMahon J. The potential of Pre-exposure Prophylaxis for women in Violent relationships. AIDS Patient Care STDs. 2016;30(6):274–81.
Cho H. Racial differences in the Prevalence of Intimate Partner Violence Against Women and Associated Factors. J Interpers Violence. 2011;27(2):344–63.
Sokoloff NJ, Dupont I. Domestic violence at the intersections of race, class, and gender: challenges and contributions to understanding violence against marginalized women in diverse communities. Violence against Women. 2005;11(1):38–64.
Satyanarayana VA, Chandra PS, Vaddiparti K. Mental health consequences of violence against women and girls. Curr Opin Psychiatry. 2015;28(5):350–6.
Zhou J, Ko JY, Haight SC, Tong VT. Treatment of Substance Use disorders among women of Reproductive Age by Depression and anxiety disorder status, 2008–2014. J Womens Health (Larchmt). 2019;28(8):1068–76.
Ramrakha S, Caspi A, Dickson N, Moffitt TE, Paul C. Psychiatric disorders and risky sexual behaviour in young adulthood: cross sectional study in birth cohort. BMJ. 2000;321(7256):263–6.
Stockman JK, Lucea MB, Campbell JC. Forced sexual initiation, sexual intimate partner violence and HIV risk in women: a global review of the literature. AIDS Behav. 2013;17(3):832–47.
Ghosh M, Rodriguez-Garcia M, Wira CR. Immunobiology of genital tract trauma: endocrine regulation of HIV acquisition in women following sexual assault or genital tract mutilation. Am J Reprod Immunol. 2013;69(Suppl 1):51–60.
Aaron E, Blum C, Seidman D, Hoyt MJ, Simone J, Sullivan M, Smith DK. Optimizing delivery of HIV Preexposure Prophylaxis for women in the United States. AIDS Patient Care STDS. 2018;32(1):16–23.
Murnane PM, Celum C, Nelly M, Campbell JD, Donnell D, Bukusi E et al. Efficacy of pre-exposure prophylaxis for HIV-1 prevention among high risk heterosexuals: subgroup analyses from the Partners PrEP Study. AIDS (London, England). 2013;27(13).
O’Malley TL, Hawk ME, Egan JE, Krier SE, Burke JG. Intimate Partner Violence and Pre-exposure Prophylaxis (PrEP): a Rapid Review of current evidence for women’s HIV Prevention. AIDS Behav. 2020;24(5):1342–57.
Smith DK, Van Handel M, Grey J. Estimates of adults with indications for HIV pre-exposure prophylaxis by jurisdiction, transmission risk group, and race/ethnicity, United States, 2015. Ann Epidemiol. 2018;28(12):850–e79.
Mayeux JJ, Ng YC. Preexposure prophylaxis for HIV prevention: a highlight of the updated clinical practice guideline. The Nurse Practitioner. 2022;47(9):44–7.
AIDSVu. Emory University, Rollins School of Public Health.; [Available from: aidsvu.org].
Ya-lin AH, Zhu W, Smith DK, Harris N, Hoover KW. HIV preexposure prophylaxis, by race and ethnicity—United States, 2014–2016. Morb Mortal Wkly Rep. 2018;67(41):1147.
Bradley E, Forsberg K, Betts JE, DeLuca JB, Kamitani E, Porter SE et al. Factors Affecting Pre-Exposure Prophylaxis Implementation for Women in the United States: A Systematic Review. Journal of women’s health (2002). 2019;28(9):1272-85.
Willie TC, Keene DE, Stockman JK, Alexander KA, Calabrese SK, Kershaw TS. Intimate Partner Violence influences women’s Engagement in the early stages of the HIV pre-exposure Prophylaxis (PrEP) care continuum: using doubly robust estimation. AIDS Behav. 2020;24(2):560–7.
Blackstock OJ, Patel VV, Felsen U, Park C, Jain S. Pre-exposure prophylaxis prescribing and retention in care among heterosexual women at a community-based comprehensive sexual health clinic. AIDS Care. 2017;29(7):866–9.
Marcus JL, Hurley LB, Hare CB, Nguyen DP, Phengrasamy T, Silverberg MJ, et al. Preexposure Prophylaxis for HIV Prevention in a large Integrated Health Care System: adherence, Renal Safety, and discontinuation. J Acquir Immune Defic Syndr. 2016;73(5):540–6.
Willie TC, Monger M, Nunn A, Kershaw T, Stockman JK, Mayer KH, et al. PrEP’s just to secure you like insurance: a qualitative study on HIV pre-exposure prophylaxis (PrEP) adherence and retention among black cisgender women in Mississippi. BMC Infect Dis. 2021;21(1):1102.
Sharpless L, Kershaw T, Hatcher A, Alexander KA, Katague M, Phillips K, Willie TC. IPV, PrEP, and Medical Mistrust. J Acquir Immune Defic Syndr. 2022;90(3):283–90.
Jeffers NK, Zemlak JL, Celius L, Willie TC, Kershaw T, Alexander KA. If the Partner finds out, then there’s trouble’: provider perspectives on Safety Planning and Partner Interference when Offering HIV pre-exposure Prophylaxis (PrEP) to women experiencing intimate Partner Violence (IPV). AIDS Behav. 2022;26(7):2266–78.
Cabral A, Baeten M, Ngure J, Velloza K, Odoyo J, Haberer JE. Intimate Partner Violence and Self-reported pre-exposure Prophylaxis interruptions among HIV-Negative partners in HIV serodiscordant couples in Kenya and Uganda. J Acquir Immune Defic Syndr. 2018;77(2):154–9.
Blumenthal J, Jain S, He F, Amico KR, Kofron R, Ellorin E, et al. Results from a pre-exposure Prophylaxis Demonstration Project for At-risk Cisgender women in the United States. Clin Infect Dis. 2021;73(7):1149–56.
US Public Health Service. Preexposure prophylaxis for the prevention of HIV infection in the United States—2014: a clinical practice guideline. Washington, DC: US Public Health Service; 2014.
Newton RR, Connelly CD, Landsverk JA. An examination of measurement characteristics and factorial validity of the revised conflict tactics Scale. Educ Psychol Meas. 2001;61(2):317–35.
Zheng JH, Rower C, McAllister K, Castillo-Mancilla J, Klein B, Meditz A, et al. Application of an intracellular assay for determination of tenofovir-diphosphate and emtricitabine-triphosphate from erythrocytes using dried blood spots. J Pharm Biomed Anal. 2016;122:16–20.
Anderson PL, Liu AY, Castillo-Mancilla JR, Gardner EM, Seifert SM, McHugh C et al. Intracellular tenofovir-diphosphate and emtricitabine-triphosphate in dried blood spots following directly observed therapy. Antimicrob Agents Chemother. 2018;62(1).
Reeves E. A synthesis of the literature on trauma-informed care. Issues Ment Health Nurs. 2015;36(9):698–709.
Sales JM, Anderson KM, Kokubun CW. Application of the Consolidated Framework for Implementation Research to facilitate violence screening in HIV Care settings: a review of the literature. Curr HIV/AIDS Rep. 2021;18(4):309–27.
Morrissey JP, Jackson EW, Ellis AR, Amaro H, Brown VB, Najavits LM. Twelve-month outcomes of trauma-informed interventions for women with co-occurring disorders. Psychiatric Serv. 2005;56(10):1213–22.
Substance Abuse and Mental Health Services Administration. Trauma-Informed Care in Behavioral Health Services. Rockville, MD: Substance Abuse and Mental Health Services Administration. 2014. Contract No.: HHS Publication No. (SMA) 13-4801.
Willie TC, Alexander KA, Kershaw T, Campbell JC, Stockman JK. No longer the exception, but the Standard: integrating trauma-informed policy and pre-exposure prophylaxis implementation for women. Womens Health Issues. 2021;31(5):415–9.
Brezing C, Ferrara M, Freudenreich O. The Syndemic illness of HIV and Trauma: implications for a trauma-informed model of Care. Psychosomatics. 2015;56(2):107–18.
Sales JM, Swartzendruber A, Phillips AL. Trauma-informed HIV, Prevention and Treatment. Curr HIV/AIDS Rep. 2016;13(6):374–82.
FDA Approves First Injectable Treatment for HIV Pre-Exposure Prevention. [press release]. U.S. Food and Drug Administration2021.
Celum C, Hosek S, Tsholwana M, Kassim S, Mukaka S, Dye BJ, et al. PrEP uptake, persistence, adherence, and effect of retrospective drug level feedback on PrEP adherence among young women in southern Africa: results from HPTN 082, a randomized controlled trial. PLoS Med. 2021;18(6):e1003670.